Clinical Trials Logo

Clinical Trial Summary

Inclusion (J0): - Information - Verification of inclusion and non-inclusion criteria - Collection of consent - MRI examination with injection of contrast product as part of the treatment comprising the sequences: T1 TFE 1.0 iso 3D FLAIR injected Injected elliptical venous angiography 0.4mm iso or less 3D SWIp multiecho 3D T1 injected FABIR iso without injection (added as part of care in case of suspected ASH or meningitis) FLAIR 1.0 without injection (added as part of care for suspected ASH or meningitis) T2 BFFE XD (added by search) FABIR iso injected (added by research) 3D PD T1 0.55 MSDE iso injected (added by research) Clinical information (SRM on inclusion, on discharge and at 3 months and recurrence within the year) will be collected from the patient's medical file


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05041569
Study type Observational
Source Fondation Ophtalmologique Adolphe de Rothschild
Contact amélie YAVCHITZ
Phone 0148036454
Email ayavchitz@for.paris
Status Recruiting
Phase
Start date December 17, 2021
Completion date December 2023